CG Oncology, Inc. Common stock
CGON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 458.3% | 6.8% | -98.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 92.1% | 99.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10,064.4% | -27,172.5% | -18,445.5% | -119.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,729.5% | -23,827% | -18,556.5% | -124% |
| EPS Diluted | -1.41 | -1.02 | -0.66 | -0.28 |
| % Growth | -38.2% | -54.5% | -135.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |